IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
75 hedge funds and large institutions have $113M invested in IVERIC bio, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 11 closing their positions.
160% more call options, than puts
Call options by funds: $674K | Put options by funds: $259K
91% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 11
15% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 20
10% more funds holding
Funds holding: 68 → 75 (+7)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
58% less capital invested
Capital invested by funds: $270M → $113M (-$157M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$8.73M |
| 2 |
DM
Deerfield Management
New York
|
+$7.41M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.49M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.8M |
| 5 |
Millennium Management
New York
|
+$2.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$8.18M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$4.51M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$4.49M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.35M |
| 5 |
Morgan Stanley
New York
|
-$3.21M |
ISEE Hedge Fund Activity: Q1 2020 in Review
75 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2020, worth a combined $113M — down 58% from $270M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new ISEE positions and 11 closed out — a net gain of 10 holders — while 23 added to existing stakes and 20 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $8.73M. The largest seller was Tamarack Advisers, cutting an estimated $8.18M.
- 75 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2020, up from 68 in Q4 2019.
- Funds reported $113M of IVERIC bio, Inc. Common Stock stock for Q1 2020, down 58% quarter-over-quarter.
- 21 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2020 and 11 closed out, a net change of +10 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q1 2020 was Baker Bros. Advisors, an estimated $8.73M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q1 2020 was Tamarack Advisers, an estimated $8.18M sold.
Based on aggregated 13F filings for Q1 2020.